Flux Peptides
$0.00 0

Cart

No products in the cart.

Research guide

Is NAD+ a Peptide? What NAD+ Actually Is

September 16, 2026

Is NAD+ a peptide? No. NAD+ (nicotinamide adenine dinucleotide) is a coenzyme built from two nucleotides joined through their phosphate groups, and it contains no amino acids and no peptide bonds. It is not a protein either, although it works alongside many enzymes.

The mix-up is understandable. Research suppliers often list NAD+ beside peptides, and it is studied in overlapping areas such as mitochondrial function and cellular aging. This guide explains what NAD+ is, why it falls outside the peptide family, and what cellular research on NAD+ has and has not shown.

Key takeaways

  • NAD+ is nicotinamide adenine dinucleotide, a coenzyme found widely in living organisms.
  • It is built from two nucleotides linked by a pyrophosphate bond, so it is neither a peptide nor a protein.
  • NAD+ carries electrons in redox reactions and is consumed by enzymes such as sirtuins, PARPs and CD38.
  • Human tissue studies link older age with lower NAD+, but whether restoring NAD+ helps aging humans is unresolved.
  • MOTS-c and SS-31 are true peptides used in mitochondrial research; NAD+ belongs to a different class of molecule.

What Is NAD+? A Coenzyme Made of Two Nucleotides

NAD+ stands for nicotinamide adenine dinucleotide. As the name suggests, it is a dinucleotide: two nucleotides joined together. One carries the base adenine, the same base found in ATP and DNA. The other carries nicotinamide, a form of vitamin B3. The two halves are linked through their phosphate groups by a pyrophosphate bond, giving the formula C21H27N7O14P2 and a molecular weight of about 663.

NAD+ is a coenzyme, a small non-protein molecule that enzymes need in order to carry out their reactions. Its best-known job is carrying electrons. The oxidized form, NAD+, accepts electrons released as nutrients are broken down and becomes NADH; NADH then hands those electrons on, including to the mitochondrial respiratory chain that produces ATP. The plus sign in the name marks that oxidized form.

In these redox reactions, NAD+ and NADH are recycled rather than used up. That sets them apart from the NAD+-consuming enzymes described below.

Illustrative 3D render of the NAD+ coenzyme molecule in violet and white ball and stick style on deep navy

Is NAD+ a Peptide? Why the Answer Is No

A peptide is a chain of amino acids joined by peptide bonds, the amide links formed between the carboxyl group of one amino acid and the amino group of the next. Short chains are peptides; long, folded chains are proteins. NAD+ fails that definition on every count:

  • No amino acids: its building blocks are nucleotides, each made of a base, a ribose sugar and a phosphate group.
  • No peptide bonds: its two halves are joined by a phosphate to phosphate (pyrophosphate) linkage.
  • Different chemistry: it contains phosphorus, which none of the standard amino acids contain.

So why does NAD+ sit next to peptides in research catalogues? The reasons are practical. It is supplied as a freeze-dried powder in sealed vials, it is stored and handled in similar ways, its purity is checked by HPLC, and it is studied in overlapping fields such as mitochondrial biology. Sharing a shelf does not make two molecules the same class, a point our guide to whether peptides are steroids makes about another common mix-up.

3D render contrasting a chain of beads with a compact ring based molecule on a deep navy background

NAD+ in Cellular Research: Redox, Sirtuins and Aging

Beyond redox chemistry, some enzymes break NAD+ apart as part of their reactions. These include sirtuins, a family of regulatory enzymes; PARPs, which take part in DNA repair; and CD38. Those links to DNA repair, gene regulation and metabolism make NAD+ supply a major research topic. What the evidence shows depends on the type of study:

  • Human tissue (cross-sectional): in skin samples from 49 people aged newborn to 77 years, NAD+ levels were lower at older ages, and in males higher PARP activity tracked with lower NAD+.
  • Reviews of animal and human data: tissue NAD+ declines with age in several organisms, including rodents and humans, but whether restoring it benefits aging humans remains an open question.
  • Small randomized trial of a precursor, NR: nicotinamide riboside raised NAD+ in blood immune cells by about 60% versus placebo in a crossover trial that randomized 30 healthy middle-aged and older adults.
  • Small randomized trial of a precursor, NMN: nicotinamide mononucleotide was reported to increase muscle insulin sensitivity over 10 weeks in postmenopausal women with prediabetes and overweight or obesity.
Illustrative 3D render of glowing mitochondria inside a cell with violet highlights on deep navy

NAD+ vs Peptides: Key Differences

The comparison uses two mitochondria-related research peptides as examples, because they are often discussed in the same context as NAD+.

Feature NAD+ MOTS-c SS-31
Molecule class Dinucleotide coenzyme Peptide Peptide
Building blocks Two nucleotides 16 amino acids 4 amino acids
Main linkage Pyrophosphate bond Peptide bonds Peptide bonds
Contains phosphorus Yes No No
Role in research Electron carrier and enzyme substrate Signalling peptide encoded in mitochondrial DNA Binds cardiolipin in the inner mitochondrial membrane

MOTS-c and SS-31: Mitochondrial Peptides, Not NAD+

MOTS-c is a 16-amino-acid peptide encoded by a short open reading frame in the mitochondrial 12S rRNA gene. In mouse studies its main target appeared to be skeletal muscle, where its actions were linked to AMPK activation, and treatment was reported to prevent insulin resistance in mice fed a high-fat diet. Flux supplies MOTS-c for laboratory research.

SS-31, also known as elamipretide, is a synthetic tetrapeptide from the Szeto-Schiller family. It binds cardiolipin, a phospholipid of the inner mitochondrial membrane, and has been studied mainly in animal models of impaired mitochondrial energy production. In September 2025 the FDA granted accelerated approval to an elamipretide medicine, Forzinity, to improve muscle strength in patients with Barth syndrome, a rare inherited disease. That medicine is prescribed by clinicians; Flux’s SS-31 research peptide is not that medicine and is not for human use.

Sourcing and Handling NAD+ for Research

Flux Peptides supplies NAD+ for laboratory research alongside its peptide range. Each order carries a batch identifier, and customers can email fluxpeptides@gmail.com with the order number and batch ID to receive the analysis for that batch. Our guide to peptide purity testing explains HPLC results, and the same principles apply to NAD+.

For temperature, light and moisture control, see how to store peptides; freeze-dried stock is held sealed at minus 20 degrees Celsius before dispatch within Canada. Flux does not publish dosing information of any kind, and its products are not for human or veterinary use.

Frequently asked questions

Is NAD+ a peptide or a protein?

Neither. Peptides and proteins are chains of amino acids linked by peptide bonds. NAD+ is a dinucleotide: two nucleotides joined through a pyrophosphate linkage, with no amino acids at all. It does work closely with proteins, because many enzymes bind NAD+ or NADH as a coenzyme, but binding to a protein does not make it one.

What is NAD plus?

NAD plus is the spoken form of NAD+, short for nicotinamide adenine dinucleotide. The plus sign marks the oxidized form of the molecule, which accepts electrons during metabolism and becomes NADH. NAD+ is also consumed by sirtuins, PARPs and CD38, which is why it features in DNA repair and cell signalling research.

Does NAD+ decline with age?

Studies report lower NAD+ in older tissue in both rodents and humans. A cross-sectional study of human skin found lower NAD+ at older ages, alongside higher PARP activity in males. Reviews note, however, that it remains unclear whether restoring NAD+ benefits aging humans, so the significance of the decline is still being studied.

Are NMN and NR the same as NAD+?

No. Nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) are precursors that cells convert into NAD+, and they are studied as ways to raise cellular NAD+. Small randomized trials have measured their effects on NAD+ levels and metabolic markers in specific groups, such as healthy older adults and women with prediabetes, but the evidence is still early.

References

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 5892, Nadide (nicotinamide adenine dinucleotide). PubChem, 2026. View source
  2. Covarrubias AJ, Perrone R, Grozio A, Verdin E. NAD+ metabolism and its roles in cellular processes during ageing. Nature Reviews Molecular Cell Biology, 2021. View source
  3. Massudi H, Grant R, Braidy N, et al. Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. PLoS One, 2012. View source
  4. Martens CR, Denman BA, Mazzo MR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nature Communications, 2018. View source
  5. Yoshino M, Yoshino J, Kayser BD, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science, 2021. View source
  6. Lee C, Zeng J, Drew BG, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metabolism, 2015. View source
  7. Szeto HH. First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics. British Journal of Pharmacology, 2014. View source
  8. US Food and Drug Administration. Accelerated approval letter, NDA 215244, Forzinity (elamipretide). FDA, 2025. View source

Flux Peptides supplies NAD+ strictly for laboratory research. It is not approved by Health Canada for human or veterinary use, and nothing in this article is medical advice.